Abrogated Freud-1/Cc2d1a Repression of 5-HT1A Autoreceptors Induces Fluoxetine-Resistant Anxiety/Depression-Like

Faranak Vahid-Ansari1, Mireille Daigle1, M Chiara Manzini2

  • 1Ottawa Hospital Research Institute (Neuroscience), University of Ottawa Brain and Mind Research Institute, Ottawa, Ontario K1H-8M5, Canada.

Insights

Freud-1 represses serotonin-1A (5-HT1A) autoreceptor transcription. Disrupting Freud-1 in mice increased 5-HT1A autoreceptors, leading to anxiety, depression, and antidepressant resistance, modeling treatment challenges.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Serotonin-1A (5-HT1A) autoreceptors regulate serotonin (5-HT) tone and are implicated in mood disorders.
  • Altered 5-HT1A autoreceptor regulation is linked to human anxiety, depression, and antidepressant resistance.

Purpose of the Study:

  • To investigate the in vivo role of the transcription factor Freud-1 in regulating 5-HT1A autoreceptors.
  • To establish a genetic mouse model for studying anxiety, depression, and antidepressant resistance.

Main Methods:

  • Generated conditional Freud-1 knockout (cF1ko) mice lacking Freud-1 in serotonin (5-HT) neurons.
  • Assessed 5-HT1A autoreceptor expression, 5-HT levels, neuronal activity, and behavioral phenotypes (anxiety, depression).
  • Utilized conditional Freud-1/5-HT1A double knockout (cF1/1A dko) mice to confirm Freud-1's role.

Main Results:

  • cF1ko mice exhibited increased 5-HT1A autoreceptor levels, reduced 5-HT content, and dorsal raphe neuronal activity.
  • cF1ko mice displayed heightened anxiety- and depression-like behaviors, resistant to fluoxetine treatment.
  • cF1/1A dko mice showed no anxiety/depression increase upon Freud-1 knockout, indicating 5-HT1A autoreceptor mediation.

Conclusions:

  • Transcriptional repression of 5-HT1A autoreceptors by Freud-1 is critical for normal anxiety and depression levels.
  • Disruption of Freud-1 in 5-HT neurons leads to a mouse model of antidepressant resistance.
  • Targeting transcription factors like Freud-1 may offer novel therapeutic strategies for mood disorders and antidepressant resistance.

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.7K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
975
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.4K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.2K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.7K